Page last updated: 2024-10-25

clonazepam and Child Development Disorders, Pervasive

clonazepam has been researched along with Child Development Disorders, Pervasive in 1 studies

Clonazepam: An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses.
clonazepam : 1,3-Dihydro-2H-1,4-benzodiazepin-2-one in which the hydrogens at positions 5 and 7 are substituted by 2-chlorophenyl and nitro groups, respectively. It is used in the treatment of all types of epilepsy and seizures, as well as myoclonus and associated abnormal movements, and panic disorders. However, its use can be limited by the development of tolerance and by sedation.

Child Development Disorders, Pervasive: Severe distortions in the development of many basic psychological functions that are not normal for any stage in development. These distortions are manifested in sustained social impairment, speech abnormalities, and peculiar motor movements.

Research Excerpts

ExcerptRelevanceReference
"This report suggests that myoclonus may be a side effect of sertraline in some adolescents."1.31Myoclonus during prolonged treatment with sertraline in an adolescent patient. ( Ghaziuddin, N; Iqbal, A; Khetarpal, S, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ghaziuddin, N1
Iqbal, A1
Khetarpal, S1

Other Studies

1 other study available for clonazepam and Child Development Disorders, Pervasive

ArticleYear
Myoclonus during prolonged treatment with sertraline in an adolescent patient.
    Journal of child and adolescent psychopharmacology, 2001,Summer, Volume: 11, Issue:2

    Topics: Adolescent; Anticonvulsants; Antidepressive Agents, Second-Generation; Attention Deficit Disorder wi

2001